Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Gastrointestinal Bleeding Treatment Devices Market?

The market size for gastrointestinal bleeding treatment devices has experienced robust expansion in recent years. This market is projected to expand from $0.92 billion in 2025 to $1 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. Historically, this growth has been driven by factors such as the increasing occurrence of gastrointestinal disorders, the rising prevalence of peptic ulcer disease, the proliferation of endoscopic diagnostic procedures, the surge in hospital-based GI interventions, and the accessibility of sophisticated endoscopy equipment.

The market for gastrointestinal bleeding treatment devices is projected to experience substantial expansion in the coming years, anticipated to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period is fueled by several factors, including the increasing integration of next-generation endoscopic devices, the rising need for outpatient GI procedures, an intensifying focus on detecting bleeding early, the expansion of ambulatory surgical centers, and growing investments in sophisticated GI care technologies. Key trends defining this period encompass the wider adoption of advanced endoscopic hemostasis devices, an increase in the utilization of minimally invasive GI bleeding treatments, a surging demand for precision thermal ablation tools, the proliferation of mechanical hemostatic solutions, and a heightened emphasis on technologies for rapid bleeding control.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

Which Drivers Are Supporting The Rise Of The Gastrointestinal Bleeding Treatment Devices Market?

The growing occurrence of gastrointestinal disorders is projected to enhance the market’s profitability. Factors such as an insufficient fiber intake, stress, inadequate hydration, excessive consumption of dairy products, a sedentary lifestyle, advancing age, and genetic predispositions can lead to gastrointestinal diseases. As an illustration, in October 2024, data from the National Library of Medicine, a US-based national library, indicated that in 2023, 825 per 100,000 Canadians were afflicted with inflammatory bowel disease (IBD), impacting over 320,000 individuals. Furthermore, forecasts suggest this figure might escalate to 1.1% of the population, which translates to approximately 470,000 Canadians, by 2035. Consequently, the rising incidence of disorders associated with the GI tract is propelling market expansion.

What Segments Are Identified Within The Structure Of The Gastrointestinal Bleeding Treatment Devices Market?

The gastrointestinal bleeding treatment devices market covered in this report is segmented –

1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

2) By GI Tract Division: Upper GI Tract, Lower GI Tract

3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

Subsegments:

1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

Which Market Trends Are Opening Growth Opportunities In The Gastrointestinal Bleeding Treatment Devices Market?

Major companies operating in the gastrointestinal bleeding treatment devices market are concentrating on developing advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the gastrointestinal (GI) tract. Hemospray functions as a hemostatic powder specifically designed to manage and control active bleeding within the GI tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, which represents a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically formulated for use in endoscopic procedures to control acute gastrointestinal (GI) bleeding. Hemospray is recognized for its ease of use, strong safety profile, and its capability to manage a wide range of GI bleeds, from conditions like peptic ulcers to variceal hemorrhages.

Which Leading Companies Dominate The Gastrointestinal Bleeding Treatment Devices Market Share?

Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

How Does The Gastrointestinal Bleeding Treatment Devices Market Perform Across Major Global Regions?

North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastrointestinal Bleeding Treatment Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

Bleeding Disorders Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Gastrointestinal Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

Bleeding Disorder Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company